Spinal cord injury
Conditions
Interventions
Control group:Routine operations
Experimental group:On the basis of routine treatment in the control group of spinal cord injury, unilateral lateral tibial bone transfer was performed at a selected time
Sponsors
Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. After admission, the spinal cord injury of the patient was evaluated by anal examination as complete spinal cord injury or incomplete injury (contusion and laceration), Asia was rated as grade C and above, and the diagnosis was in line with the international standard for neurological classification of spinal cord injury issued by the American spinal cord injury society; 2. Spinal cord injury was diagnosed by CT, X-ray or MRI; 3. There is obvious trauma in the spine, and after the injury, he has undergone spinal cord decompression surgery (or) received different kinds of neurotrophic or neurofactor treatment and rehabilitation treatment; 4. There are different degrees of motor, sensory and sphincter dysfunction below the spinal injury segment; 5. Aged >= 18 and < 70 years, regardless of gender; 6. The main organs of the subjects including heart, liver, lung and kidney function well; 7. Be informed of the test before the start of the test, and voluntarily sign the name and date of the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Complicated with brain injury, combined thoracic and abdominal organ injury, unstable vital signs or disturbance of consciousness; 2. Coagulation dysfunction; 3. There are obvious mental diseases; 4. Previous history of lumbar surgery and trauma, lumbar fracture, infection, tumor and severe osteoporosis; 5. Patients with complications affecting the detection of nerve function, such as neuralgia, limb spasm and ectopic ossification around joints; 6. Combined with other causes, resulting in failure of neurological function examination; 7. Pregnant or lactating women; 8. Serious medical or infectious diseases (including but not limited to hepatitis B virus carriers and human immunodeficiency virus carriers); 9. Participants in other clinical trials; 10. Any situation that the investigator believes may increase the risk of the subject or interfere with the results of the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| American Spinal Cord Injury Association (Asia) classification;Modified Barthel Index; | — |
Countries
China
Contacts
Public ContactBai Xiaochun
Southern Medical University
Outcome results
None listed